Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and
pathogenesis are largely unknown despite advances in molecular science. Hepatic …

Background Biliary atresia (BA) is one of the most challenging hepatobiliary diseases in
children. Notwithstanding the reasonable outcome of liver transplantation (LT), portoenteral …

Background: Biliary atresia (BA) has unclear etiology, leading to cholestasis and cirrhosis.
Kasai portoenterostomy has been accepted worldwide as the primary treatment for …

Biliary atresia is a rare, serious and challenging disease in newborn children. Its aetiology
remains unknown. Optimal management at specialist centres with resultant better overall …

Although the prognosis of biliary atresia has been dramatically improved in the era of liver
transplantation, the Kasai operation is still the first line of surgical treatment. Successful …

Kasai's portoenterostomy is, so far, the only option for patients with biliary atresia (BA) to
survive with their own liver. The long-term results are closely related to the timing of the …

Biliary atresia (BA) is a severe hepatobiliary disease in infancy characterized by a
progressive, fibro-obliterative process affecting extrahepatic as well as intrahepatic bile …

Biliary atresia (BA), a chronic progressive cholestatic disease of infants, is the leading cause
for liver transplant in children, especially in patients under two years of age. BA can be …

Biliary atresia (BA) still remains one of the most intractable gastrointestinal diseases in
infancy dispite the concerted efforts of pediatric surgeons all over the world. The introduction …

Abstract Background Biliary atresia (BA) is the end result of an inflammatory process leading
to fibrosis and obliteration of the biliary tract with the development of biliary cirrhosis. It is a …